Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Bioorganic Chemistry|June 26, 2014
Applications of structure-based design to antibacterial drug discoveryRicky Cain, Sarah Narramore, Martin McPhillie, et al.Cancer Letters|February 12, 2017
A chemical genomics approach to drug reprofiling in oncology: Antipsychotic drug risperidone as a potential adenocarcinoma treatmentSuzanne J Dilly, Andrew J Clark, Andrew Marsh, et al.Scientific Reports|July 30, 2020
Anti-biofilm efficacy of a medieval treatment for bacterial infection requires the combination of multiple ingredientsJessica Furner-Pardoe, Blessing O Anonye, Ricky Cain, et al.Journal of Medicinal Chemistry|August 1, 2013
Assay platform for clinically relevant metallo-β-lactamasesSander S van Berkel, Jürgen Brem, Anna M Rydzik, et al.Molecular Microbiology|September 7, 2017
Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolatesKarina Calvopiña, Philip Hinchliffe, Jürgen Brem, et al.Nature Communications|August 9, 2016
Structural basis of metallo-β-lactamase, serine-β-lactamase and penicillin-binding protein inhibition by cyclic boronatesJürgen Brem, Ricky Cain, Samuel Cahill, et al.Journal of Medicinal Chemistry|October 19, 2019
Structure-Guided Enhancement of Selectivity of Chemical Probe Inhibitors Targeting Bacterial Seryl-tRNA SynthetaseRicky Cain, Ramya Salimraj, Avinash S Punekar, et al.Bioorganic & Medicinal Chemistry Letters|June 8, 2019
Profiling interactions of vaborbactam with metallo-β-lactamasesGareth W Langley, Ricky Cain, Jonathan M Tyrrell, et al.Antimicrobial Agents and Chemotherapy|January 25, 2017
Cyclic Boronates Inhibit All Classes of β-LactamasesSamuel T Cahill, Ricky Cain, David Y Wang, et al.Journal of Medicinal Chemistry|December 23, 2017
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase InhibitorsRicky Cain, Jürgen Brem, David Zollman, et al.Pageof 2